These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8623441)

  • 1. Deoxyspergualin: clinical experience.
    Gores PF
    Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract]   [Full Text] [Related]  

  • 3. Further study of deoxyspergualin prophylaxis in living related renal transplantation.
    Okazaki H; Sato T; Amada N
    Transplant Proc; 1993 Feb; 25(1 Pt 1):772-3. PubMed ID: 8438475
    [No Abstract]   [Full Text] [Related]  

  • 4. 15-Deoxyspergualin in experimental transplant models: a review.
    Kaufman DB
    Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01.
    Amemiya H
    Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
    Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
    [No Abstract]   [Full Text] [Related]  

  • 7. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Fukunishi Y; Hanafusa T; Nagano S; Takahara S; Ishibashi M; Okuyama A; Ihara H; Fujimoto N
    Transplant Proc; 1995 Feb; 27(1):1012-3. PubMed ID: 7878780
    [No Abstract]   [Full Text] [Related]  

  • 9. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract]   [Full Text] [Related]  

  • 11. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
    Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation.
    Suzuki S; Hayashi R; Kenmochi T; Shimatani K; Fukuoka T; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1615-7. PubMed ID: 2389422
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract]   [Full Text] [Related]  

  • 14. Deoxyspergualin in allogeneic kidney and xenogeneic islet transplantation: early clinical trials.
    Groth CG
    Ann N Y Acad Sci; 1993 Jun; 685():193-5. PubMed ID: 8363222
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
    Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
    [No Abstract]   [Full Text] [Related]  

  • 16. Deoxyspergualin--a different and intriguing immunosuppressant.
    Tufveson G; Gannedahl G
    Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of deoxyspergualin to standard triple immunosuppressive regimen in kidney transplantation.
    Seki T; Tanda K; Chikaraishi T; Takeuchi I; Kanagawa K; Togashi M; Koyanagi T
    Transplant Proc; 1996 Jun; 28(3):1352-3. PubMed ID: 8658690
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 15-deoxyspergualin on mononuclear cells from kidney recipients.
    Johansson-Borg A; Ohlman S; Groth CG
    Transplant Proc; 1992 Feb; 24(1):267-8. PubMed ID: 1539276
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
    Fudaba Y; Fukuda Y; Yamamoto H; Ohdan H; Shintaku S; Shibata S; Miyata Y; Marubayashi S; Asahara T; Dohi K
    Transplant Proc; 1998 Nov; 30(7):3582-3. PubMed ID: 9838569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.